McCarter & English Used Doctrine As ‘Whipsaw,’ Panel Hears

By Editorial Team

A biotech company has urged a New Jersey appellate panel to revive its legal malpractice suit against McCarter & English LLP. The company argued that the claims were distinct from the firm’s own suit seeking unpaid fees.

The biotech company presented its case before the panel, alleging that McCarter & English LLP had used a legal doctrine as a ‘whipsaw.’ The company’s legal malpractice suit aims to hold the law firm accountable for its actions.

McCarter & English LLP, a prominent law firm, is facing scrutiny over its handling of the biotech company’s legal matters. The appellate panel is now tasked with evaluating the merits of the biotech company’s claims and determining whether the legal malpractice suit should proceed.

Legal experts anticipate that the outcome of this case could have significant implications for both the biotech company and McCarter & English LLP. The decision of the appellate panel will shape the future trajectory of the legal dispute between the parties.

Stay tuned for further updates on this developing legal story as the appellate panel deliberates on the fate of the legal malpractice suit against McCarter & English LLP.